The Journey of Lung Cancer Patients in France: A Look at Treatment Choices and Results
In France, patients with advanced or metastatic non-small cell lung cancer (LAM NSCLC) have been given nivolumab as a second-line or later treatment. This drug is part of a group known as immune checkpoint inhibitors, which help the body's immune system fight cancer. The study focused on how patient